Phase 3 IMAgINE-1 Trial Results Of Adalimumab In Pediatric Crohn's Disease

Pediatric Crohn's Disease is a chronic, debilitating condition of the gastrointestinal (GI) tract that affects up to 200,000 children worldwide. CD, which is a type of inflammatory bowel disease (IBD), most commonly involves the end of the small intestine and the beginning of the large intestine. The disease can pose a substantial psycho-social burden to younger patients and is associated with reduced quality of life for both patients and their caregivers. Pediatric CD is characterized by...